• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放线菌属及相关微生物在药物性颌骨坏死(MRONJ)发生发展中的作用:基于病例系列的临床证据

Role of Actinomyces spp. and related organisms in the development of medication-related osteonecrosis of the jaw (MRONJ): Clinical evidence based on a case series.

作者信息

Kövér Zsanett, Bán Ágnes, Gajdács Márió, Polgár Beáta, Urbán Edit

机构信息

1Department of Dentistry, Oral and Maxillofacial Surgery, Medical School, University of Pécs, Tüzér u. 1., 7623 Pécs, Hungary.

2Department of Oral Biology and Experimental Dental Research, Faculty of Dentistry, University of Szeged, Tisza Lajos krt. 64-66., 6725, Szeged, Hungary.

出版信息

Eur J Microbiol Immunol (Bp). 2023 Dec 1;13(4):125-134. doi: 10.1556/1886.2023.00041. Print 2023 Dec 21.

DOI:10.1556/1886.2023.00041
PMID:38038751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10755666/
Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is an increasingly common consequence of antiresorptive treatment, which often leads to the development of necrotic exposed bone surfaces with inflammatory processes affecting the jawbone. Although the development of MRONJ is often associated with the inflammatory response or infections caused by the colonizing members of the oral microbiota, the exact pathogenesis of MRONJ is still not fully understood. In the present paper, we aimed to provide additional, microbiological culture-supported evidence, supporting the "infection hypothesis" that Actinomyces spp. and related organisms may play an important pathogenic role in the development of MRONJ and the resulting bone necrosis. In our case series, all patients presented with similar underlying conditions and anamnestic data, and have received antiresorptive medications (bisphosphonates or a RANK ligand (RANKL) inhibitor) to prevent the occurrence or progression of bone metastases, secondary to prostate cancer. Nevertheless, a few years into antiresorptive drug therapy, varying stages of MRONJ was identified in the mentioned patients. In all three cases, quantitative microbiological culture of the necrotic bone samples yielded a complex microbiota, dominated by Actinomyces and Schaalia spp. with high colony counts. Additionally, our followed-up case series document the treatment of these patients with a combination of surgical intervention and long-term antibiotic therapy, where favourable clinical responses were seen is all cases. If the "infection hypothesis" is valid, it may have significant consequences in the preventative and therapeutic strategies associated with this disease.

摘要

药物相关性颌骨坏死(MRONJ)是抗吸收治疗越来越常见的后果,常导致坏死暴露骨面的形成,并伴有影响颌骨的炎症过程。尽管MRONJ的发生通常与口腔微生物群定殖成员引起的炎症反应或感染有关,但其确切发病机制仍未完全明确。在本文中,我们旨在提供更多微生物培养支持的证据,以支持“感染假说”,即放线菌属及相关微生物可能在MRONJ的发生及由此导致的骨坏死中起重要致病作用。在我们的病例系列中,所有患者均有相似的基础疾病和既往史,且均接受了抗吸收药物(双膦酸盐或核因子κB受体活化因子配体(RANKL)抑制剂)以预防继发于前列腺癌的骨转移的发生或进展。然而,在抗吸收药物治疗数年后,上述患者中发现了不同阶段的MRONJ。在所有3例病例中,坏死骨样本的定量微生物培养均显示出以放线菌属和沙雷菌属为主、菌落计数高的复杂微生物群。此外,我们的随访病例系列记录了这些患者采用手术干预和长期抗生素治疗相结合的治疗方法,所有病例均观察到了良好的临床反应。如果“感染假说”成立,可能会对与该疾病相关的预防和治疗策略产生重大影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e6/10755666/09fc9955f01c/eujmi-13-125-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e6/10755666/e7d405ee0a78/eujmi-13-125-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e6/10755666/d505f32dda43/eujmi-13-125-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e6/10755666/09fc9955f01c/eujmi-13-125-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e6/10755666/e7d405ee0a78/eujmi-13-125-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e6/10755666/d505f32dda43/eujmi-13-125-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e6/10755666/09fc9955f01c/eujmi-13-125-g003.jpg

相似文献

1
Role of Actinomyces spp. and related organisms in the development of medication-related osteonecrosis of the jaw (MRONJ): Clinical evidence based on a case series.放线菌属及相关微生物在药物性颌骨坏死(MRONJ)发生发展中的作用:基于病例系列的临床证据
Eur J Microbiol Immunol (Bp). 2023 Dec 1;13(4):125-134. doi: 10.1556/1886.2023.00041. Print 2023 Dec 21.
2
Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw.感染性颌骨骨髓炎患者的微生物多样性
Clin Oral Investig. 2019 May;23(5):2143-2151. doi: 10.1007/s00784-018-2655-z. Epub 2018 Oct 1.
3
The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection.药物相关性颌骨坏死与放线菌属感染的关联。
Sci Rep. 2016 Aug 17;6:31604. doi: 10.1038/srep31604.
4
Interventions for managing medication-related osteonecrosis of the jaw.干预措施管理与药物相关的颌骨坏死。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3.
5
Role of microbiological culture and polymerase chain reaction (PCR) of actinomyces in medication-related osteonecrosis of the jaw (MRONJ).放线菌的微生物培养和聚合酶链反应(PCR)在药物相关性颌骨坏死(MRONJ)中的作用。
J Craniomaxillofac Surg. 2017 Mar;45(3):357-363. doi: 10.1016/j.jcms.2017.01.006. Epub 2017 Jan 9.
6
Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies.不同原发性癌症及药物治疗相关颌骨骨坏死(MRONJ)的影像学评估
Cureus. 2023 Aug 1;15(8):e42830. doi: 10.7759/cureus.42830. eCollection 2023 Aug.
7
Shotgun metagenome sequencing identification of a set of genes encoded by Actinomyces associated with medication-related osteonecrosis of the jaw.通过 shotgun 宏基因组测序鉴定与药物相关性颌骨坏死相关的放线菌编码的一组基因。
PLoS One. 2020 Nov 30;15(11):e0241676. doi: 10.1371/journal.pone.0241676. eCollection 2020.
8
[Position paper on medication-related osteonecrosis of the jaw (MRONJ)].[关于药物性颌骨坏死(MRONJ)的立场文件]
Wien Med Wochenschr. 2016 Feb;166(1-2):68-74. doi: 10.1007/s10354-016-0437-2.
9
Targeted histological evaluation shows high incidence of actinomyces infection in medication-related osteonecrosis of the jaws.靶向组织学评估显示,药物相关性颌骨坏死中放线菌感染的发生率很高。
Sci Rep. 2022 Mar 1;12(1):3406. doi: 10.1038/s41598-022-07375-1.
10
Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.颌骨骨坏死与良性及恶性疾病中的抗吸收药物:由 ECTS 组织的批判性回顾。
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888.

引用本文的文献

1
The Microbiological Background of Medication-Related Osteonecrosis of the Jaw (MRONJ): Clinical Evidence Based on Traditional Culture and Molecular Biological Detection Methods.颌骨药物相关性骨坏死(MRONJ)的微生物学背景:基于传统培养和分子生物学检测方法的临床证据
Antibiotics (Basel). 2025 Feb 15;14(2):203. doi: 10.3390/antibiotics14020203.
2
Clinical Performance of Implant-Supported Prostheses in the Rehabilitation of Patients Previously Treated for Medication-Related Osteonecrosis of the Jaws (MRONJ): A Systematic Review.种植体支持式修复体用于曾接受药物相关性颌骨坏死(MRONJ)治疗患者康复的临床性能:一项系统评价
Cureus. 2024 Jun 4;16(6):e61658. doi: 10.7759/cureus.61658. eCollection 2024 Jun.
3

本文引用的文献

1
The role of Actinomyces spp. and related organisms in cervicofacial infections: Pathomechanism, diagnosis and therapeutic aspects.放线菌属及相关生物在头颈部感染中的作用:发病机制、诊断和治疗方面。
Anaerobe. 2023 Aug;82:102767. doi: 10.1016/j.anaerobe.2023.102767. Epub 2023 Jul 22.
2
Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan.抗骨吸收剂相关颌骨坏死的发病率:日本兵库县的一项多中心回顾性流行病学研究。
J Dent Sci. 2023 Jul;18(3):1156-1163. doi: 10.1016/j.jds.2022.10.030. Epub 2022 Nov 8.
3
Medication-related osteonecrosis of the jaw: A literature review and update.
Development of selective isolation media for detecting the genera Actinomyces and Schaalia from oral specimens containing indigenous bacteria.
用于从含有本土细菌的口腔标本中检测放线菌属和 Schaalia 属的选择性分离培养基的开发。
Access Microbiol. 2024 May 10;6(5). doi: 10.1099/acmi.0.000768.v3. eCollection 2024.
药物相关性下颌骨坏死:文献回顾与更新。
Genesis. 2022 Sep;60(8-9):e23500. doi: 10.1002/dvg.23500. Epub 2022 Sep 15.
4
sp. Presence in the Bone Specimens of Patients with Osteonecrosis of the Jaw: The Histopathological Analysis and Clinical Implication.颌骨坏死患者骨标本中的[具体物种]:组织病理学分析及临床意义
Antibiotics (Basel). 2022 Aug 5;11(8):1067. doi: 10.3390/antibiotics11081067.
5
Oral microbiota in human systematic diseases.口腔微生物群与人类系统性疾病。
Int J Oral Sci. 2022 Mar 2;14(1):14. doi: 10.1038/s41368-022-00163-7.
6
Targeted histological evaluation shows high incidence of actinomyces infection in medication-related osteonecrosis of the jaws.靶向组织学评估显示,药物相关性颌骨坏死中放线菌感染的发生率很高。
Sci Rep. 2022 Mar 1;12(1):3406. doi: 10.1038/s41598-022-07375-1.
7
Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).感染是导致药物相关性颌骨坏死(MRONJ)的一个重要因素。
Medicina (Kaunas). 2021 May 9;57(5):463. doi: 10.3390/medicina57050463.
8
The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw.免疫反应在药物相关性颌骨坏死发展中的作用。
Front Immunol. 2021 Feb 25;12:606043. doi: 10.3389/fimmu.2021.606043. eCollection 2021.
9
Actinomyces and MRONJ: A retrospective study and a literature review.放线菌与放射性颌骨坏死:一项回顾性研究及文献综述。
J Stomatol Oral Maxillofac Surg. 2021 Nov;122(5):499-504. doi: 10.1016/j.jormas.2020.07.012. Epub 2020 Aug 20.
10
The incidence of anaerobic bacteria in adult patients with chronic sinusitis: A prospective, single-centre microbiological study.成年慢性鼻窦炎患者中厌氧菌的发生率:一项前瞻性单中心微生物学研究。
Eur J Microbiol Immunol (Bp). 2020 Jun 5;10(2):107-114. doi: 10.1556/1886.2020.00010.